US EditionCancer Stem Cells-Derived Exosomal TSPAN8 Enhances Non-Stem Cancer Cells Stemness and Promotes Malignant Progression in PDAC
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Cancer Stem Cells-Derived Exosomal TSPAN8 Enhances Non-Stem Cancer Cells Stemness and Promotes Malignant Progression in PDAC
Investigators employed single-cell RNA sequencing and exosomal profiling, identifying TSPAN8-enriched exosomes secreted by CSC, which were associated with poor survival rates in pancreatic ductal adenocarcinoma patients. [Oncogene] Abstract
The Latest Talk in Cancer Immunotherapy: A Brief Overview of Developments & Current Players in the Exosome Space
Exosomes are making waves in cancer research. These tiny vesicles, about 40-150 nanometers, carry proteins, nucleic acids, and lipids. They shuttle messages between cells, influencing … The Latest Talk in Cancer Immunotherapy: A Brief Overview of Developments & Current Players in the Exosome Space Read More » The post The Latest Talk in Cancer Immunotherapy: A Brief Overview of Developments & Current Players in the Exosome Space first appeared o…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage